Learn More
Medchemexpress LLC 4-[[4-oxo-2-thioxo-3-[[3-(trifluoromethyl)phenyl]methyl]-5-thiazolidinylidene]methyl]benzoic acid | 1073612-91-5 | MFCD31619349 | 99.6% | 423.43 g/mol | C19H12F3NO3S2 | 1 MG

Supplier: Medchemexpress LLC HY1036661MG
Selective, direct small-molecule inhibitor of the NLRP3 inflammasome that binds the ATP-binding motif of the NLRP3 NACHT domain and inhibits NLRP3 ATPase activity. Supplied as a light-yellow solid and provided in milligram-scale solids or pre-prepared DMSO solution formats for research applications.
- Selective NLRP3 inhibitor that blocks ATPase activity.
- Direct binding to the ATP-binding motif of the NLRP3 NACHT domain.
- High stated purity (99.6%).
- Light yellow solid; soluble in DMSO for solution preparation.
- Available in milligram-scale solids and 10 mM DMSO solutions.
- Intended for in vitro and in vivo research; not for human use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.